1,305 results on '"Ruan BY"'
Search Results
2. BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
3. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation
4. Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models
5. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
6. Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
7. Efficacy and Safety of Low-Dose Venetoclax Combined with Voriconazole Inpatients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
8. Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma
9. The potential for chemotherapy-free strategies in mantle cell lymphoma
10. Postibrutinib outcomes in patients with mantle cell lymphoma
11. Signaling-mediated cooperativity between glycoprotein Ib-IX and protease-activated receptors in thrombin-induced platelet activation
12. Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphomas: The Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (LEO-MER) Prospective Cohort Study
13. Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma
14. Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets
15. The Safety and Efficacy of p CAR-19B, a Scfv Humanlized CD19-Directed CAR-T for Patients with Relapsed/Refactory (R/R) CD19+ B-ALL
16. Phase 2 Trial of Acalabrutinib-Lenalidomide-Rituximab (ALR) with Real-Time Monitoring of MRD in Patients with Treatment-Naïve Mantle Cell Lymphoma
17. High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group
18. Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study
19. Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphomas: The Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (LEO-MER) Prospective Cohort Study
20. Hypomagnesemia and Prognosis in Newly Diagnosed Diffuse Large B Cell Lymphoma
21. Cold Exposure Induces Vaso-Occlusion and Hyperalgesia in Mice with Sickle Cell Disease That Is Dependent on Complement Activation
22. Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia
23. Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia：Study of a Single Center from China
24. Efficacy of MEK Inhibitors in Erdheim Chester Disease
25. Gastrointestinal Manifestation of Langerhans Cell Histiocytosis
26. Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes
27. MGUS and SMM Plasma Cells Exhibit a Senescence-like Phenotype and Accumulation of Transposable Elements That May Contribute to Disease Progression
28. A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia withFLT3-ITDMutation
29. An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)
30. Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome
31. Overcoming Barriers to T Cell Therapy Against AML with Dual Costimulatory Receptors
32. Claiming the mantle of the brain
33. Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma
34. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
35. LIM kinase-1 selectively promotes glycoprotein Ib-IX–mediated TXA2 synthesis, platelet activation, and thrombosis
36. Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets
37. Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study
38. Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes
39. Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome
40. An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)
41. The Safety and Efficacy of p CAR-19B, a Scfv Humanlized CD19-Directed CAR-T for Patients with Relapsed/Refactory (R/R) CD19+ B-ALL
42. Overcoming Barriers to T Cell Therapy Against AML with Dual Costimulatory Receptors
43. High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group
44. Gastrointestinal Manifestation of Langerhans Cell Histiocytosis
45. Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia
46. A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with FLT3-ITD Mutation
47. Cold Exposure Induces Vaso-Occlusion and Hyperalgesia in Mice with Sickle Cell Disease That Is Dependent on Complement Activation
48. MGUS and SMM Plasma Cells Exhibit a Senescence-like Phenotype and Accumulation of Transposable Elements That May Contribute to Disease Progression
49. Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia：Study of a Single Center from China
50. Efficacy of MEK Inhibitors in Erdheim Chester Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.